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The guanine nucleotide regulatory proteins (G-proteins) which are substrates for ADP-ribosylation by pertussis toxin 
(G(,.,. a,.r, c(,.) and a,) transduce a variety of hormonal signals. Endothelial cells express mRNA for three a, subtypes al- 
though the level of a,_, mRNA is very low. Interleukin 18 (ILIB), a pleiotropic inflammatory mediator which stimulates 
a complex series of responses in human endothehal cells leading to increased coagulation and platelet adhesion, increases 
expression of one subtype of a, (LX_*) mRNA in human endothehal cells as determined by Northern blot analysis without 
affecting the level of mRNA for other a-subunits. These studies show that mRNA levels for a, subtypes are independently 
regulated, suggesting that there may be subtype specificity in the cell’s requirements for the G, class of signal-transducing 
proteins. 
Interleukin 1; Guanine nucleotide regulatory protein; mRNA; (Endothelial cell) 
1. INTRODUCTION 
G-proteins are heterotrimers comprised of LY-, & 
and y-subunits and are distinguished by variations 
in a-subunits (reviews [ 1,2]). The a-subunits of G, 
(as) which mediate stimulation of adenylate cyclase 
and regulate ion channels can be covalently 
modified by cholera toxin-catalyzed ADP- 
ribosylation. Another family of G-protein w 
subunits are substrates for covalent modification 
by pertussis toxin. Two members of this family are 
expressed only in the retina. In other cells, 
members of this family are involved in hormonal 
regulation of inositol phdspholipid metabolism, 
arachidonic acid release, and ion channels. Several 
cDNAs have been identified for LY proteins in this 
group that each contain a putative site for ADP- 
ribosylation by pertussis toxin [ 1,2]. The proteins 
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encoded by these cDNAs have been called ai_1, ai_2, 
ai- and LYE. In addition, another type of a-subunit, 
called CY=, has recently been identified which is dif- 
ferent from ays, but also lacks the site for ADP- 
ribosylation by pertussis toxin [3,4]. The function 
of this G-protein a-subunit is not yet known. 
The three forms of ai are extremely similar to 
each other (human ai- is 94% identical to ai- and 
85% identical to ui-2). It is not yet known whether 
they have independent functions or whether the cell 
can use any member of the group interchangeably. 
Reconstitution experiments argue for a great deal 
of cross-talk among G-protein a-subunits [l]. On 
the other hand, the strict conservation of ai sub- 
type sequences across species uggests that the sub- 
tle differences in the isoforms are, in fact, impor- 
tant. 
Interleukin 1P (ILl) is a pleiotropic inflam- 
matory mediator that exerts diverse effects upon 
lymphocytes and many other cell types [5], in- 
cluding cultured human endothelial cells (HEC) 
[6]. ILl,& effects on HEC apparently require DNA 
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and protein synthesis; however, little else is known 
about intracellular events underlying ILlfi target 
cell responses. G-proteins appear to transduce 
signals important in endothelial growth and in- 
ositolphospholipid metabolism (in preparation). 
Because ILL& regulates many endothelial cell func- 
tions, including responses initiated at the plasma 
membrane [6-lo], we postulated that ILlfl may 
alter expression of G proteins which transduce a 
variety of transmembrane signals. We now show 
that activation of the ILl,& receptor in endothelial 
cells can lead to changes in the level of mRNA for 
one ai subtype, but not for others. Independent 
regulation of ai subtype mRNA provides another 
line of evidence that there may be separate roles for 
the ai subtypes. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
Human umbilical vein endothelial cells from 2 -5 cords were 
isolated and grown as described [6]. The cultures were 100% en- 
dothelial cells as judged from DiI-Ac-LDL uptake; Dil-Ac- 
LDL, acetylated low density lipoprotein reacted with 1,l ‘-di- 
octadecyl-3,3,3’,3 ‘-tetramethylindocarbocyanine perchlorate 
1111. 
2.2. RNA analysis 
Total cellular RNA was prepared by the guanidine isothio- 
cyanate/cesium chloride method [12]. Northern analysis was 
performed using “P-labeled probes described below. Filters 
were washed twice at 52°C (bovine or rat probes) or 65°C 
(human probes) in 0.1% SDS and 0.2 x SSC (1 x SSC = 0.15 M 
NaCI/lS mM sodium citrate, pH 7.0). To quantitate the 
amount of RNA loaded on agarose gels, a 15fold molar excess 
of a “P-labeled oligonucleotide probe (5 ‘-ACGGTATCTGAT- 
CGTCTTCGAACC-3’) complementary to rat 18 S ribosomal 
RNA [13] was hybridized to filters. For each experimental 
observation , at least two Northern blots were performed with 
18 S standardizations. RNA sizes were determined by com- 
parison to synthetic RNA markers (Bethesda Research 
Laboratories, Bethesda, MD). Autoradiograms were scanned 
using an LKB 2222-010 Ultroscan XL laser densitometer. The 
absorbance of bands was expressed as a multiple of the control. 
The one-sample t-test was used to compare experimental data. 
Data are expressed as means + SD. 
2.3. Probes 
Because of the high degree of conservation of the G-protein 
a-subunits rat probes for oi_z, my0 and (Y~ react specifically with 
their counterparts in human mRNA. Initial experiments were 
performed with the rat probe for ~-2, os and (Y~ kindly provided 
by Dr R. Reed (Johns Hopkins University, Baltimore, MD) and 
partial bovine cDNA clone for or.1 and ai. (ah) which we had 
previously reported [ 141. For rat cDNAs the EcoRI insert which 
contained the full coding sequence was used to probe Northern 
blots. For bovine ai. we used the SmaI-Xba fragment described 
140 
by Michel et al. [14]. Subsequently, this laboratory isolated 
cDNA clones for human ui_l, ai. and at-s. Selected experiments 
were repeated with the “P-labeled human cDNA probes to 
verify the conclusions reached with heterologous probes as well 
as to extend the studies to human oi-3. The cDNA fragments 
used as probes were the same as those detailed by Kim et al. [15]. 
2.4. ADP-ribosylation 
ADP-ribosylation of lysed endothelial cells by pertussis toxin 
was performed as described, except that the reaction mixture 
also contained 0.1% Lubrol Px (Lubrol 12A9, ICI) and 0.015% 
bovine serum albumin [16]. Two-dimensional gel electro- 
phoresis was carried out as described by O’Farrell et al. [17]. 
3. RESULTS AND DISCUSSION 
3.1. IL I,.8 increases mi-2 mRNA in HEC 
We have previously shown that human umbilical 
vein endothelial cells express easily measurable 
mRNA for ai- and 09-3, but very low amounts of 
ai- mRNA [ 151. A rat cDNA for ai- recognized a 
prominent 2.5 kb species and a much less promi- 
nent 3.1 kb species in mRNA from HEC cells 
(fig. 1). After treatment of HEC with recombinant 
ILl,& (Cistron Biotechnology, Pine Brook, NJ) for 
24,48 or 72 h, the quantity of predominant 2.5 kb 
mRNA (measured by densitometry of auto- 
radiograms) increased 1.6 f 0.6, 2.6 f 0.4, and 
3.5 f 1.0 fold, respectively (n = 4, p<O.Ol). The 
amount of 18 S RNA in each lane was quantitated 
with an oligonucleotide probe (see section 2). This 
measurement was used as a control to monitor the 
amount of RNA loaded in each lane. There was no 
increase in hybridization of a 32P-labeled mouse p- 
actin cDNA in HEC treated with ILlP (not shown). 
The ILl&induced increase in ai- mRNA was dose- 
dependent, with peak response at 5 U/ml (fig.%). 
When human cDNA probes became available, we 
reanalyzed the filters with human ai- cDNA and 
obtained identical results to those with the rat ai- 
cDNA. The increase in mRNA level was specific to 
the ai- subtypes, since we found no increase in ai- 
mRNA (fig.2) using human ai- cDNA probes. 
There was also no increase in the very low level of 
ai- mRNA. The same filters were also analyzed for 
ai- and ai. mRNA and found to contain the ex- 
pected levels of mRNA for these subtypes. 
Therefore, the very small amount of ai- mRNA 
detected was not due to degradation of mRNA or 
loading of insufficient mRNA. HEC RNA 
hybridized to rat crys cDNA revealed a 2.0 kb RNA 
species; however, no consistent increase was 
observed after ILlp treatment. The rat my0 cDNA 
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Fig.1. ILlp induces an increase in cui-like mRNA in cultured 
human endothelial cells. HEC were incubated with 5 U/ml of 
ILlp for 0, 1, 2, or 3 days. For this Northern analysis, 10~ 
total cellular RNA was loaded on each lane. Hybridization to 
rat ai cDNA revealed a 2.5 kb RNA species and a 3.1 kb species 
(poorly visible on this exposure). Below, the hybridization of an 
oligonucleotide complementary to 18 S ribosomal RNA shows 
that equal amounts of RNA were loaded. This Northern blot is 
representative of 4 similar experiments. 
failed to recognize mRNA species in HEC RNA 
despite the use of enhancing screens and prolonged 
autoradiogram exposures. 
Vascular endothelial cells respond to inflam- 
matory mediators with a variety of effects. Some of 
these effects, such as leukocyte adhesion and 
platelet-activating factor production, occur during 
the first hours of treatment [6]. However, other ef- 
fects such as prostacyclin synthesis [lo] and in- 
creased plasminogen activator inhibitory activity 
1719 require longer incubation periods. ILlp 
specifically increases the levels ai- mRNA with a 
dose-response pattern which closely parallels the 
induction of procoagulant and regulation of the 
fibrinolytic system [8]. The increase in ai- mRNA 
in HEC in response to ILlfl occurs gradually over 
the first 3 days of exposure, suggesting that G- 
protein regulation is not involved in the generation 
O 1 o_’ I I I I I 
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Fig.2. Dose response of ut-2 mRNA in HEC treated with ILIP. 
Cells were treated with varying ILl,6 concentrations for 3 days 
and the total cellular RNA was analyzed as in fig.2. Data are 
expressed as the ratio of the absorbance of the 2.5 kb ai-2 mRNA 
to that of the 18 S RNA. This experiment is representative of 3 
similar experiments: (0) ai. (results are shown with rat ut-2; 
similar results were obtained with human (~i.2); (0) ui_3 (human 
ai. probe). 
of early procoagulant activity but may play a role 
in the later events of the inflammatory response. 
3.2. HEC contain multiple substrates for ADP- 
ribosylation by pertussis toxin 
Fig.3A shows the pattern of ADP-ribosylated cy- 
subunits in control and ILl&treated HEC. On 
one-dimensional gel electrophoresis, we were un- 
able to detect any change in amount of [32P]ADP- 
ribose incorporated into the pertussis toxin sub- 
strates. Addition of exogenous brain &subunit 
did not alter the pattern (not shown). Although en- 
dothelial cells contain multiple kinds of ai- 
subunits, we could not detect more than one band 
on a one-dimensional SDS PAGE. 
Two-dimensional gel electrophoresis does reveal 
the heterogeneity of cri-subunits in endothelial cells 
(fig.3). The major ADP-ribosylated a-subunit of 
endothelial cells migrates similarly to ADP- 
141 
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Fig.3. Endothelial cells were incubated for 3 days with or 
without 5 U/ml ILl,&. Cells were harvested, lysed and ADP- 
ribosylated as described in section 2. (A) Autoradiogram of a 
one-dimensional SDS-PAGE analysis of control and treated 
cells. Both lanes were loaded with 44 pg protein. (B) Two- 
dimensional gel analysis of samples shown in A. On two- 
dimensional analysis we sometimes saw a radioactive approx. 35 
kDa spot below the major pertussis toxin substrate. The spot 
was very faintly present on a one-dimensional gel. We do not 
know what this spot represents but there was no change in this 
spot in ILl&treated cells. 
ribosylated myi- purified from bovine brain (not 
shown), and probably represents endothelial cell 
ai-2. Two-dimensional gels revealed no change in 
the amount of any ADP-ribosylated protein after 
interleukin I,& treatment. Antibodies would allow a 
more definitive assignment of subtype, but we were 
unable to obtain sufficiently strong signals from 
anti-peptide antibodies for reliable identification 
or quantitation. 
An increase in an ai- protein might not be de- 
tectable by the methods we used because it might be 
considerably smaller than the increase in mRNA 
level. Since ai- is the most abundant isoform in the 
unstimulated HEC, small changes would be dif- 
ficult to document. Alternatively, the newly 
formed protein might not be a substrate for ADP- 
ribosylation by pertussis toxin. The interaction of 
pertussis toxin with the G-protein subunits is com- 
plex and may not reflect changes in the amount of 
a specific a-subunit. The development of more sen- 
sitive immunological methods will be needed to 
allow us to measure possible changes in G-protein 
levels. 
These studies demonstrate that mRNA levels for 
the subtypes of the err-like proteins are in- 
dependently regulated. We do not know whether 
regulation is at the level of transcription or mRNA 
stability. The independent regulation of ai subtype 
mRNA suggests that the ai subtypes may not be in- 
terchangeable, but that the cell may require specific 
subtypes for specific functions. 
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